Connecticut Innovations

Connecticut Innovations

Connecticut Innovations is a venture capital firm financing and supporting innovative companies in Connecticut.

Connecticut Innovations is a venture capital firm that prefers to invest in clean technology, manufacturing, nanotechnology, life sciences, infrastructure, biotechnology, information technology, energy, photonics and e-commerce sectors. The firm was established in 1989 and is based in Rocky Hill, Connecticut.

Connecticut Innovations provides strategic capital and operational insight to companies. Their mission is to be the leading source of financing and ongoing support for Connecticut's growing companies. By offering flexible financing, strategic guidance and introductions to valuable partners, Connecticut Innovations enable promising businesses to thrive.

Exits

Connecticut Innovations exited investments include Arvinas, Achillion Pharmaceuticals, iDevices, Biohaven Pharmaceutical, eBrevia, SeeClickFix, Cara Therapeutics, NXT-ID, Dextro and CyVek.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
Cara Therapeutics

A company developing treatments for pain, inflammation and pruritus

A company based in Farmington, Connecticut, that develops skin disease treatments using microbiome science and technology.

The Rapid Oxygen Company is a medical technology company that primarily develops, manufactures and markets, portable oxygen generators used to deliver emergency oxygen to the commercial and consumer markets.

Etouches is a company founded by Leonora Valvo.

Continuity Control is a company founded by Andy Greenawalt.

A company that develops a microbiome discovery platform for animal health.

A pharmaceutical company developing protein degradation drugs to treat cancer and other diseases

A company developing wearable bioelectronic devices for the delivery of sustained acoustic medicine

Aureus Analytics is an AI platform for customer experience in the insurance industry.

A bio-renewable chemistry company developing and producing specialty chemicals using renewable feedstocks

IsoPlexis is a Branford, Connecticut-based healthcare company developing a cellular response analysis platform.

Queralt, Inc. was founded as an Applied Research & Development organization focused on the identity, authentication and access layer of the security framework.

Precipio Diagnostics is a New Haven, Connecticut-based company developing a platform delivering diagnostic technology.

A genomics company developing and commercializing microRNA-based diagnostic tests for breast and ovarian cancer

A company developing diagnostic medical devices for the detection of cerebrospinal fluid leaks and early-stage prostate cancer

A company that develops technology devices for measuring analytes in biological samples.

XLerant is a Stamford, Connecticut-based software company founded in 2005.

Pattern Genomics is a Madison, Connecticut-based molecular diagnostics company developing next-generation sequencing and bioinformatics for molecular diagnostics.

Frevvo is a Branford, Connecticut-based enterprise software company.

A company developing technology for the automated, high-throughput selection of human monoclonal antibodies

A company developing therapeutics for the treatment of central nervous system injury

A pharmaceutical company developing drugs to treat cardiovascular disease

A company focused on recombinant antibody development

Continuity Engine is a New Haven, Connecticut-based company.

53 Results
Results per page:
Page 1 of 3

People

Name
Role
LinkedIn

Brendan Burns

Employee

Carrie Collins White

Employee

Douglas Roth

Employee

Glendowlyn Thames

Employee

Karen Mendes

Employee

Lend R

Investor

Matt Storeygard

Employee

Matthew Bloom

Employee

Michael Wisniewski

Employee

Mike Wisniewski

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.